250 related articles for article (PubMed ID: 32129948)
1. Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery.
Kung CH; Tsai JA; Lundell L; Johansson J; Nilsson M; Lindblad M
BJS Open; 2020 Jun; 4(3):424-431. PubMed ID: 32129948
[TBL] [Abstract][Full Text] [Related]
2. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
3. Modified radical lymphadenectomy (D1.5) for T2-3 gastric cancer.
Ichikura T; Chochi K; Sugasawa H; Mochizuki H
Langenbecks Arch Surg; 2005 Sep; 390(5):397-402. PubMed ID: 16041552
[TBL] [Abstract][Full Text] [Related]
4. Gastric cancer: Current status of lymph node dissection.
Degiuli M; De Manzoni G; Di Leo A; D'Ugo D; Galasso E; Marrelli D; Petrioli R; Polom K; Roviello F; Santullo F; Morino M
World J Gastroenterol; 2016 Mar; 22(10):2875-93. PubMed ID: 26973384
[TBL] [Abstract][Full Text] [Related]
5. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
[TBL] [Abstract][Full Text] [Related]
6. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
7. Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.
Chen JH; Cai SR; Zhai ET; Chen SL; Wu KM; Song W; He YL
Int J Clin Exp Pathol; 2015; 8(11):14365-73. PubMed ID: 26823752
[TBL] [Abstract][Full Text] [Related]
8. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
Cornejo C; Portanova M
Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
[TBL] [Abstract][Full Text] [Related]
10. D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial.
Degiuli M; Reddavid R; Tomatis M; Ponti A; Morino M; Sasako M;
Eur J Cancer; 2021 Jun; 150():10-22. PubMed ID: 33887514
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
12. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.
Verlato G; Giacopuzzi S; Bencivenga M; Morgagni P; De Manzoni G
World J Gastroenterol; 2014 Sep; 20(36):12883-91. PubMed ID: 25278685
[TBL] [Abstract][Full Text] [Related]
13. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
15. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Extended Lymphadenectomy for Gastroesophageal Carcinoma: A Large Western Series.
Li SS; Costantino CL; Rattner DW; Mullen JT
J Am Coll Surg; 2019 Jun; 228(6):879-891. PubMed ID: 30825638
[TBL] [Abstract][Full Text] [Related]
17. Complications of gastrectomy with lymphadenectomy in gastric cancer.
Zilberstein B; Martins BC; Jacob CE; Bresciani C; Lopasso FP; de Cleva R; Pinto Junior PE; Junior UR; Perez RO; Gama-Rodrigues J
Gastric Cancer; 2004; 7(4):254-9. PubMed ID: 15616774
[TBL] [Abstract][Full Text] [Related]
18. Surgical and oncological outcomes of D1 versus D2 gastrectomy among elderly patients treated for gastric cancer.
Back J; Sallinen V; Kokkola A; Puolakkainen P
Scand J Surg; 2022; 111(2):14574969221096193. PubMed ID: 35611500
[TBL] [Abstract][Full Text] [Related]
19. Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis?
Zhang J; Zou S; Luo R; Zhu Z; Wang Z; Xu H; Huang B
Clin Transl Oncol; 2019 Dec; 21(12):1699-1706. PubMed ID: 30977046
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
